Skip to content

AtriCure ATRC Debt-to-equity

Debt-to-equity at other companies

Abbott logo
AbbottABT
0.7×+0.4×
Johnson & Johnson logo
Johnson & JohnsonJNJ
0.7×0.0×
Boston Scientific logo
Boston ScientificBSX
-0.5×
Medtronic logo
MedtronicMDT
0.6×0.0×
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
0.1×0.0×
ITG
Integer HoldingsITGR
0.8×0.0×

Other financials

Income statement

See full
Revenue$141.2M+14.3%
Gross profit$109.3M+18.0%
Operating income$526.0K+109%
Net income$108.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$146.2M+46.3%
Total debt$76.2M-3.1%
Total equity$491.7M+8.2%
Total assets$644.0M+8.8%

Cash flow

See full
Operating cash flow-$4.0M+63.8%
CapEx$3.9M+76.6%
Free cash flow-$7.8M+40.6%

Valuation

See full
Market cap$1.43B-9.9%
Enterprise value$1.36B-13.1%
P/S2.6×-0.7×

Profitability

See full
Gross margin75.6%+0.8pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.7%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Current ratio4.3×+0.2×

Where this comes from

Calculated from AtriCure’s reported figures.

Based on the most recent quarter.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AtriCure's debt-to-equity?
AtriCure (ATRC) reported debt-to-equity of 0.2× in Q1 2026.
How has AtriCure's debt-to-equity changed year-over-year?
AtriCure's debt-to-equity decreased by 10.5% year-over-year, from 0.2× to 0.2×.
What is the long-term trend for AtriCure's debt-to-equity?
Over 5 years (2020 to 2025), AtriCure's debt-to-equity has grown at a -2.5% compound annual growth rate (CAGR), from 0.2× to 0.2×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.